Specific lymphocyte proliferative response in vitro after cDNA HBsAg immunization.
Degrassi
A
A
Istituto di Clinica Medica e Gastroenterologia, Università di Bologna, Italy.
Mariani
E
E
Roda
P
P
Miniero
R
R
Capelli
M
M
Honorati
M C
MC
Astaldi
A
A
Facchini
A
A
D000328:Adult; D003208:Concanavalin A / Q000494:pharmacology; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000276:immunology*; D008297:Male; D011863:Radioimmunoassay; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014614:Vaccines, Synthetic / Q000276:immunology; D014761:Viral Hepatitis Vaccines / Q000276:immunology*
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D007376:Interleukin-2; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; D014316:Tritium; D003208:Concanavalin A; D013936:Thymidine